{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T09:19:43Z","timestamp":1782811183267,"version":"3.54.5"},"reference-count":16,"publisher":"Elsevier","isbn-type":[{"value":"9780128186732","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008430","name":"Fundaci\u00f3n para el Fomento en Asturias de la Investigaci\u00f3n Cient\u00edfica Aplicada y la Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008430","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16 \/01485"],"award-info":[{"award-number":["PI16 \/01485"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/bs.mie.2019.05.036","type":"book-chapter","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T19:07:09Z","timestamp":1560884829000},"page":"483-495","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay"],"prefix":"10.1016","member":"78","reference":[{"issue":"2","key":"10.1016\/bs.mie.2019.05.036_bb0010","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1074378","article-title":"Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors","volume":"5","author":"Acebes-Huerta","year":"2016","journal-title":"Oncoimmunology"},{"issue":"7","key":"10.1016\/bs.mie.2019.05.036_bb0015","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andre","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/bs.mie.2019.05.036_bb0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","article-title":"Natural killer cells and other innate lymphoid cells in cancer","volume":"18","author":"Chiossone","year":"2018","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.mie.2019.05.036_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.smim.2017.08.003","article-title":"Natural killer cell immunotherapies against cancer: Checkpoint inhibitors and more","volume":"31","author":"Chiossone","year":"2017","journal-title":"Seminars in Immunology"},{"issue":"6383","key":"10.1016\/bs.mie.2019.05.036_bb0030","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.aao0505","article-title":"Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity","volume":"359","author":"Ferrari de Andrade","year":"2018","journal-title":"Science"},{"issue":"459","key":"10.1016\/bs.mie.2019.05.036_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1126\/scitranslmed.aat7807","article-title":"The hallmarks of successful anticancer immunotherapy","volume":"10","author":"Galluzzi","year":"2018","journal-title":"Science Translational Medicine"},{"issue":"8","key":"10.1016\/bs.mie.2019.05.036_bb0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.it.2008.04.007","article-title":"NKG2D ligands: Key targets of the immune response","volume":"29","author":"Gonzalez","year":"2008","journal-title":"Trends in Immunology"},{"issue":"9","key":"10.1016\/bs.mie.2019.05.036_bb0045","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ni.3518","article-title":"Targeting natural killer cells in cancer immunotherapy","volume":"17","author":"Guillerey","year":"2016","journal-title":"Nature Immunology"},{"issue":"7143","key":"10.1016\/bs.mie.2019.05.036_bb0050","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature05768","article-title":"Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands","volume":"447","author":"Kaiser","year":"2007","journal-title":"Nature"},{"issue":"25","key":"10.1016\/bs.mie.2019.05.036_bb0055","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1038\/onc.2009.117","article-title":"HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: Potential implications for the immunosurveillance of cancer","volume":"28","author":"Lopez-Soto","year":"2009","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/bs.mie.2019.05.036_bb0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","article-title":"Control of metastasis by NK cells","volume":"32","author":"Lopez-Soto","year":"2017","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/bs.mie.2019.05.036_bb0065","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ijc.28775","article-title":"NKG2D signaling in cancer immunosurveillance","volume":"136","author":"Lopez-Soto","year":"2015","journal-title":"International Journal of Cancer"},{"issue":"8","key":"10.1016\/bs.mie.2019.05.036_bb0070","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.4049\/jimmunol.1202950","article-title":"Epithelial-mesenchymal transition induces an antitumor immune response mediated by NKG2D receptor","volume":"190","author":"Lopez-Soto","year":"2013","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.mie.2019.05.036_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc.2015.5","article-title":"NK cells and cancer: You can teach innate cells new tricks","volume":"16","author":"Morvan","year":"2016","journal-title":"Nature Reviews. Cancer"},{"issue":"6","key":"10.1016\/bs.mie.2019.05.036_bb0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: Function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","journal-title":"Nature Reviews. Immunology"},{"issue":"7","key":"10.1016\/bs.mie.2019.05.036_bb0085","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nature Immunology"}],"container-title":["Methods in Enzymology","Tumor Immunology and Immunotherapy \u2013 Cellular Methods Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007668791930206X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007668791930206X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:26:45Z","timestamp":1758749205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S007668791930206X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128186732"],"references-count":16,"URL":"https:\/\/doi.org\/10.1016\/bs.mie.2019.05.036","relation":{},"ISSN":["0076-6879"],"issn-type":[{"value":"0076-6879","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}